Kaisa Health Group Holdings Limited logo

Kaisa Health Group Holdings Limited

0876.HK

HKSEHealthcareMedical - Instruments & Supplies

Latest quote

HK$1.92

+HK$0.01 · +0.52%

Aug 21, 3:54 PM HKT

0876.HK company overview

Historical prices · Market data may be delayed.

Company profile

Company website

Kaisa Health Group Holdings Limited, an investment holding company, engages in the health care and dental business in the People's Republic of China and internationally. It produces and sells dental prosthetics, including crowns and bridges, removable full and partial dentures, implants, and full-cast restorations, as well as provides sport rehabilitation services comprising postoperative rehabilitation, sports injury rehabilitation, chronic pain, scoliosis, deformity correction, and other rehabilitation services; and health leisure services. The company is also involved in the investment holding of loan receivable; provision of medical consultation and other medical services; and trading and provision of medical technology development. In addition, it trades in dental prosthetics, implant instruments, and other dental products. The company was formerly known as Mega Medical Technology Limited and changed its name to Kaisa Health Group Holdings Limited in January 2018. Kaisa Health Group Holdings Limited was founded in 1971 and is headquartered in Central, Hong Kong.

Industry
Medical - Instruments & Supplies
Sector
Healthcare
Headquarters
HK
CEO
Jun Luo
Listed since
Sep 29, 2005
Employees
825

Market position

52-week range

Current HK$1.92

Open
HK$1.92
Previous close
HK$1.91
Volume
2K
0.06× average
Average volume
34.09K
Average daily volume
Market cap
193.62M HKD
Beta
1.12
Market reference 1
50-day average
HK$2.094
-8.31% below average
200-day average
HK$5.0078
-61.66% below average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

Enterprise value
-89.08M HKD
EV / EBITDA
1.84×
Earnings yield
-661.21%
Free cash flow yield
-827.40%

Profitability & efficiency

Return on equity
-11.57%
Return on assets
-9.90%
Return on invested capital
-13.43%

Financial health

Current ratio
3.98×

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin
Gross, operating, and net margin trends58%13%-31%-75%Gross margin, FY2021: 46.47%Gross margin, FY2022: 43.12%Gross margin, FY2023: 43.62%Gross margin, FY2024: 44.16%Gross margin, FY2025: 36.41%Operating margin, FY2021: -24.43%Operating margin, FY2022: -36.39%Operating margin, FY2023: -21.99%Operating margin, FY2024: -12.53%Operating margin, FY2025: -39.82%Net margin, FY2021: 1.13%Net margin, FY2022: -64.40%Net margin, FY2023: 4.02%Net margin, FY2024: -25.01%Net margin, FY2025: -33.55%FY2021FY2022FY2023FY2024FY2025
Gross margin FY2021 46.47%. Gross margin FY2022 43.12%. Gross margin FY2023 43.62%. Gross margin FY2024 44.16%. Gross margin FY2025 36.41%. Operating margin FY2021 -24.43%. Operating margin FY2022 -36.39%. Operating margin FY2023 -21.99%. Operating margin FY2024 -12.53%. Operating margin FY2025 -39.82%. Net margin FY2021 1.13%. Net margin FY2022 -64.40%. Net margin FY2023 4.02%. Net margin FY2024 -25.01%. Net margin FY2025 -33.55%.

Income trends

Revenue

139.11M HKD-24.95%

Operating income

−55.4M HKD-138.50%

Net income

−46.68M HKD-0.70%
Income trends across reported periods242.92M HKD109.74M HKD−23.43M HKD−156.61M HKDRevenue, FY2021: 209.63M HKDRevenue, FY2022: 191.5M HKDRevenue, FY2023: 185.88M HKDRevenue, FY2024: 185.36M HKDRevenue, FY2025: 139.11M HKDOperating income, FY2021: −51.21M HKDOperating income, FY2022: −69.68M HKDOperating income, FY2023: −40.88M HKDOperating income, FY2024: −23.23M HKDOperating income, FY2025: −55.4M HKDNet income, FY2021: 2.36M HKDNet income, FY2022: −123.32M HKDNet income, FY2023: 7.47M HKDNet income, FY2024: −46.36M HKDNet income, FY2025: −46.68M HKDFY2021FY2022FY2023FY2024FY2025
Revenue FY2021 209.63M HKD. Revenue FY2022 191.5M HKD. Revenue FY2023 185.88M HKD. Revenue FY2024 185.36M HKD. Revenue FY2025 139.11M HKD. Operating income FY2021 −51.21M HKD. Operating income FY2022 −69.68M HKD. Operating income FY2023 −40.88M HKD. Operating income FY2024 −23.23M HKD. Operating income FY2025 −55.4M HKD. Net income FY2021 2.36M HKD. Net income FY2022 −123.32M HKD. Net income FY2023 7.47M HKD. Net income FY2024 −46.36M HKD. Net income FY2025 −46.68M HKD.
Metric (HKD)FY2025FY2024FY2023FY2022FY2021
Revenue139.11M HKD185.36M HKD185.88M HKD191.5M HKD209.63M HKD
Cost of goods sold88.47M HKD103.5M HKD104.81M HKD108.93M HKD112.21M HKD
Gross profit50.64M HKD81.86M HKD81.07M HKD82.57M HKD97.42M HKD
Research and development16.91M HKD12.48M HKD16.84M HKD17.43M HKD17.22M HKD
Selling, general, and administrative89.13M HKD93.59M HKD110.24M HKD134.82M HKD157.3M HKD
Operating expenses106.04M HKD105.08M HKD127.08M HKD152.25M HKD148.62M HKD
Interest income781K HKD1.32M HKD3.08M HKD3.01M HKD1.32M HKD
Interest expense592K HKD779K HKD3.67M HKD7.73M HKD8.18M HKD
Depreciation and amortization7.09M HKD10.52M HKD17.89M HKD31.21M HKD26.19M HKD
Operating income−55.4M HKD−23.23M HKD−40.88M HKD−69.68M HKD−51.21M HKD
Net income−46.68M HKD−46.36M HKD7.47M HKD−123.32M HKD2.36M HKD

Company facts updated Aug 24, 2026.

Earnings

Latest EPS result
-4.5

EPS: actual versus estimate

Recent quarterly results

ActualEstimate
Estimates unavailable
Quarterly EPS actual values compared with estimates25.17-1.03-27.22-53.42Q3 '22Q1 '23Q3 '23Q1 '24Q3 '24Q1 '25Q2 '25
Q3 2022, reported Aug 29, 2022: actual -48, estimate —, surprise —, Comparison unavailable. Q1 2023, reported Mar 28, 2023: actual -13, estimate —, surprise —, Comparison unavailable. Q3 2023, reported Aug 28, 2023: actual 19.75, estimate —, surprise —, Comparison unavailable. Q1 2024, reported Mar 25, 2024: actual -16.25, estimate —, surprise —, Comparison unavailable. Q3 2024, reported Aug 27, 2024: actual -12, estimate —, surprise —, Comparison unavailable. Q1 2025, reported Mar 24, 2025: actual -11, estimate —, surprise —, Comparison unavailable. Q2 2025, reported Jun 13, 2025: actual -4.5, estimate —, surprise —, Comparison unavailable.

Revenue: actual versus estimate

Recent quarterly results

ActualEstimate
Estimates unavailable
Quarterly Revenue actual values compared with estimates101.42M89.51M77.59M65.68MQ3 '22Q1 '23Q3 '23Q1 '24Q3 '24Q1 '25Q2 '25
Q3 2022, reported Aug 29, 2022: actual 93.98M HKD, estimate —, surprise —, Comparison unavailable. Q1 2023, reported Mar 28, 2023: actual 97.52M HKD, estimate —, surprise —, Comparison unavailable. Q3 2023, reported Aug 28, 2023: actual 92.59M HKD, estimate —, surprise —, Comparison unavailable. Q1 2024, reported Mar 25, 2024: actual 93.29M HKD, estimate —, surprise —, Comparison unavailable. Q3 2024, reported Aug 27, 2024: actual 88.52M HKD, estimate —, surprise —, Comparison unavailable. Q1 2025, reported Mar 24, 2025: actual 96.84M HKD, estimate —, surprise —, Comparison unavailable. Q2 2025, reported Jun 13, 2025: actual 69.58M HKD, estimate —, surprise —, Comparison unavailable.

Corporate actions

Corporate action history

Stock split

Effective Jun 24, 2026

1:50

Stock split

Effective Sep 23, 2014

8:1

Stock split

Effective Jan 17, 2006

2:1

Stock split

Effective Feb 1, 2005

3:1

0876.HK peers

Continue in GoAI

Research 0876.HK

research.disclaimer